LUNG vs MASS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

LUNG

55.1
AI Score
VS
LUNG Wins

MASS

46.7
AI Score

Investment Advisor Scores

LUNG

55score
Recommendation
HOLD

MASS

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG MASS Winner
Revenue 43.34M 29.46M LUNG
Net Income -23.73M -23.85M LUNG
Gross Margin 78.0% 51.7% LUNG
Net Margin -54.8% -81.0% LUNG
Operating Income -22.01M -25.69M LUNG
ROE -60.6% -18.8% MASS
ROA -20.7% -12.1% MASS
Total Assets 114.73M 197.54M MASS
Cash 55.84M 63.02M MASS
Current Ratio 4.32 2.67 LUNG
Free Cash Flow -15.32M 4.17M MASS

Relative Price Performance (Last 90 Days)

LUNG 1M: -19.7% · 3M: +23.6% MASS 1M: +22.8% · 3M: +50.7%

Current Technical Phase

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.0 · Price: $1.83

MASS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.5% over 20 days), RSI 74

RSI (14): 74.0 · Price: $12.69

Fundamentals Snapshot

Metric LUNG MASS
Market Cap — —
Forward P/E -1.9 -42.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.8% 0.5%
Operating Margin -0.4% -0.4%
EPS -1.15 -0.94
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.